JINZHEN for Treatment of Mild to Moderate COVID-19
Status:
Not yet recruiting
Trial end date:
2023-03-01
Target enrollment:
Participant gender:
Summary
JINZHEN is a botanical drug that contains eight chemical constituents extracted from plant,
mineral and animal origin raw materials. This study is to evaluate the safety and efficacy of
JINZHEN Granules for Oral Solution compared to placebo for treatment of mild to moderate
COVID-19 outpatients.